|
Press Releases |
|
|
|
Tuesday, April 16, 2024 |
|
中国抗体SM17治疗特应性皮炎(AD)之临床前结果刊登于国际科学期刊《Allergy》 |
more info >> |
|
中國抗體SM17治療特應性皮炎(AD)之臨床前結果刊登於國際科學期刊《Allergy》 |
more info >> |
|
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy |
SinoMab BioScience announced preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy. more info >> |
|
Tuesday, September 12, 2023 |
|
中国抗体SM17新药研究申请再获国家药监局批准 |
专注研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司—中国抗体制药有限公司(上市编号:3681.HK,下称“中国抗体”或“本公司”)欣然宣布,本公司所提交之治疗特应性皮炎(“AD”)的同类首创(First-in-Class)治疗产品SM17的新药研究申请(“新药研究申请”) more info >> |
|
中國抗體SM17新藥研究申請再獲國家藥監局批准 |
專注研究、發展、製造及商業化免疫性疾病療法的香港生物製藥公司—中國抗體製藥有限公司(上市編號:3681.HK,下稱「中國抗體」或「本公司」)欣然宣佈,本公司所提交之治療特應性皮炎(「AD」)的同類首創(First-in-Class)治療產品SM17的新藥研究申請(「新藥研究申請」) more info >> |
|
SinoMab's IND Application of SM17 has once again Received Approval from NAMP |
A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialisation of therapeutics for the treatment of immunological diseases- SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
Monday, August 14, 2023 |
|
中国抗体SM17针对治疗哮喘疾病的新药研究申请获国家药监局批准 |
专注研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司—中国抗体制药有限公司(上市编号:3681.HK,下称“中国抗体”或“本公司”)欣然宣布,本公司所提交之治疗哮喘的同类首创(First-in-Class)治疗产品SM17的新药研究申请(“新药研究申请”)于2023年8月11日获中国国家药品监督管理局(“国家药监局”)批准。 more info >> |
|
中國抗體SM17針對治療哮喘疾病的新藥研究申請獲國家藥監局批准 |
專注研究、發展、製造及商業化免疫性疾病療法的香港生物製藥公司—中國抗體製藥有限公司(上市編號:3681.HK,下稱「中國抗體」或「本公司」)欣然宣佈,本公司所提交之治療哮喘的同類首創(First-in-Class)治療產品SM17的新藥研究申請(「新藥研究申請」)於2023年8月11日獲中國國家藥品監督管理局(「國家藥監局」)批准。 more info >> |
|
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP |
A Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases- SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company") more info >> |
|
Monday, June 12, 2023 |
|
中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎(AD)的新药研究申请获国家药监局药品审评中心受理 |
专注研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司—中国抗体制药有限公司(上市编号:3681.HK,下称“中国抗体”或“本公司”)欣然宣布,SM17(注射用人源化抗IL-17RB单克隆抗体)针对治疗特应性皮炎(AD)的新药研究申请已于6月9日获中国国家药品监督管理局(“国家药监局”)药品审评中心受理。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Xeleb Joins Miss Charm as Exclusive Web3 Partner to Revolutionize Voting and Judging with Decentralization
Dec 13, 2024 10:50 HKT/SGT
|
|
|
Asia Video Industry Association Wraps Up 2024 Harnessing the Power of Advertising to Spur the Industry Forward
Dec 13, 2024 10:35 HKT/SGT
|
|
|
Loop Industries Completes Convertible Preferred Financing With Reed Societe Generale Group and Sells First Technology License For An Infinite Loop Manufacturing Facility in Europe
Dec 13, 2024 09:10 HKT/SGT
|
|
|
Accurate Background Appoints Mark Thompson Managing Director, Australia and APAC
Dec 13, 2024 07:00 HKT/SGT
|
|
|
Notification of Dissolution of Joint Management of LT Metal Co., Ltd. by TANAKA Kikinzoku Kogyo K.K. and LT Corp.
Dec 13, 2024 4:00 JST
|
|
|
BBMSL与Yedpay HK强势联手推出全新品牌'AbbyPay'
Dec 12, 2024 22:35 HKT/SGT
|
|
|
Virturo Unveils Next-Gen CFD Trading Platform Empowered by AI and Human Expertise
Dec 12, 2024 22:30: JST
|
|
|
BBMSL與Yedpay HK強勢聯手推出全新品牌「AbbyPay」
Dec 12, 2024 22:30 HKT/SGT
|
|
|
Huatai Securities Hosts FinTech Summit in Hong Kong
Dec 12, 2024 22:25 HKT/SGT
|
|
|
Hong Kong's exports set for 4% growth in 2025
Dec 12, 2024 22:20 HKT/SGT
|
|
|
The Payment Cards Group Limited and Black Bear Merchant Services Limited Join Forces to Launch a New Brand 'AbbyPay'
Dec 12, 2024 22:10 HKT/SGT
|
|
|
慶祝安安可可到港 霸王茶姬聯合《HELLO PANDAS 熊貓駕到》戶外嘉年華
Dec 12, 2024 22:08 HKT/SGT
|
|
|
CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers
Dec 12, 2024 22:00 HKT/SGT
|
|
|
Virturo Unveils Next-Gen CFD Trading Platform Empowered by AI and Human Expertise
Dec 12, 2024 21:30 HKT/SGT
|
|
|
Brawijaya University develops data system for climate change monitoring
Dec 12, 2024 21:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|